Nova In Silico
Nova In Silico provides AI-driven clinical trial simulations to speed up and de-risk drug development. Its jinkō platform uses modeling and simulation, digital patients, and disease models to predict outcomes and optimize trial design for pharma and biotech customers. Built on AI, data science, biology, medicine, and applied mathematics, it serves as a SaaS solution that integrates with standard pharma workflows. The company targets pharmaceutical companies and clinical trial sponsors, aiming to reduce trial duration, risk to participants, and overall cost while enabling faster market access.
Nova In Silico
Nova In Silico provides AI-driven clinical trial simulations to speed up and de-risk drug development. Its jinkō platform uses modeling and simulation, digital patients, and disease models to predict outcomes and optimize trial design for pharma and biotech customers. Built on AI, data science, biology, medicine, and applied mathematics, it serves as a SaaS solution that integrates with standard pharma workflows. The company targets pharmaceutical companies and clinical trial sponsors, aiming to reduce trial duration, risk to participants, and overall cost while enabling faster market access.